CN110974832A - 一种注射用头孢孟多酯钠的制备方法 - Google Patents
一种注射用头孢孟多酯钠的制备方法 Download PDFInfo
- Publication number
- CN110974832A CN110974832A CN201911078093.9A CN201911078093A CN110974832A CN 110974832 A CN110974832 A CN 110974832A CN 201911078093 A CN201911078093 A CN 201911078093A CN 110974832 A CN110974832 A CN 110974832A
- Authority
- CN
- China
- Prior art keywords
- cefamandole nafate
- solution
- ethyl acetate
- preparation
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911078093.9A CN110974832B (zh) | 2019-11-06 | 2019-11-06 | 一种注射用头孢孟多酯钠的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911078093.9A CN110974832B (zh) | 2019-11-06 | 2019-11-06 | 一种注射用头孢孟多酯钠的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110974832A true CN110974832A (zh) | 2020-04-10 |
CN110974832B CN110974832B (zh) | 2021-03-02 |
Family
ID=70083267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911078093.9A Active CN110974832B (zh) | 2019-11-06 | 2019-11-06 | 一种注射用头孢孟多酯钠的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110974832B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111875621A (zh) * | 2020-08-26 | 2020-11-03 | 山东鲁抗医药股份有限公司 | 一种注射用头孢菌素盐的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102093392A (zh) * | 2011-01-28 | 2011-06-15 | 海南灵康制药有限公司 | 一种头孢孟多酯钠的新制法 |
CN102276629A (zh) * | 2011-08-22 | 2011-12-14 | 苏州二叶制药有限公司 | 一种头孢孟多酯钠的合成路线 |
CN106511281A (zh) * | 2016-09-30 | 2017-03-22 | 华北制药河北华民药业有限责任公司 | 一种注射用头孢孟多酯钠粉针制剂的制备方法 |
CN106565749A (zh) * | 2016-09-30 | 2017-04-19 | 华北制药河北华民药业有限责任公司 | 利用立体塔板纯化溶剂提升头孢孟多酯钠质量的方法 |
CN107915750A (zh) * | 2017-11-28 | 2018-04-17 | 华北制药河北华民药业有限责任公司 | 一种头孢孟多酯钠粉针制剂的制备方法 |
CN110302202A (zh) * | 2016-09-30 | 2019-10-08 | 华北制药河北华民药业有限责任公司 | 制备注射用头孢孟多酯钠粉针制剂的方法 |
-
2019
- 2019-11-06 CN CN201911078093.9A patent/CN110974832B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102093392A (zh) * | 2011-01-28 | 2011-06-15 | 海南灵康制药有限公司 | 一种头孢孟多酯钠的新制法 |
CN102276629A (zh) * | 2011-08-22 | 2011-12-14 | 苏州二叶制药有限公司 | 一种头孢孟多酯钠的合成路线 |
CN106511281A (zh) * | 2016-09-30 | 2017-03-22 | 华北制药河北华民药业有限责任公司 | 一种注射用头孢孟多酯钠粉针制剂的制备方法 |
CN106565749A (zh) * | 2016-09-30 | 2017-04-19 | 华北制药河北华民药业有限责任公司 | 利用立体塔板纯化溶剂提升头孢孟多酯钠质量的方法 |
CN110302202A (zh) * | 2016-09-30 | 2019-10-08 | 华北制药河北华民药业有限责任公司 | 制备注射用头孢孟多酯钠粉针制剂的方法 |
CN107915750A (zh) * | 2017-11-28 | 2018-04-17 | 华北制药河北华民药业有限责任公司 | 一种头孢孟多酯钠粉针制剂的制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111875621A (zh) * | 2020-08-26 | 2020-11-03 | 山东鲁抗医药股份有限公司 | 一种注射用头孢菌素盐的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110974832B (zh) | 2021-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105399754B (zh) | 一种头孢孟多酯钠的制备方法 | |
CN102268019B (zh) | 一种头孢羟氨苄化合物及其制法 | |
CN102268016A (zh) | 一种阿莫西林钠的制备方法 | |
CN110974832B (zh) | 一种注射用头孢孟多酯钠的制备方法 | |
CN110452255A (zh) | 头孢曲松钠的晶型及其制备方法 | |
CN112535666A (zh) | 一种高稳定性注射用头孢呋辛钠粉针制剂的制备方法 | |
CN104341435A (zh) | 头孢曲松钠的精制方法 | |
CN114874237B (zh) | 一种头孢噻肟钠的精制方法 | |
CN111471057A (zh) | 一种溶媒结晶制备美洛西林钠的工艺 | |
CN106565749B (zh) | 利用立体塔板纯化溶剂提升头孢孟多酯钠质量的方法 | |
US8871927B2 (en) | Method for purifying Ceftizoxime sodium | |
CN108586491B (zh) | 一种盐酸头孢他美酯的制备方法 | |
CN102391259A (zh) | 一种硝呋太尔化合物及其制法 | |
CN102432645A (zh) | 一种硫酸依替米星的纯化方法 | |
CN105440054A (zh) | 一种制备高纯度头孢硫脒的工艺 | |
CN108707158B (zh) | 一种硫酸头孢匹罗的纯化方法 | |
CN112679524B (zh) | 一种头孢曲松钠的制备方法 | |
CN114349768A (zh) | 一种头孢噻肟酸的制备方法 | |
CN107793432B (zh) | 头孢曲松钠粗盐的精制方法 | |
CN111777625B (zh) | 一种注射用头孢唑肟钠的制备方法 | |
CN109503630A (zh) | 一种去乙酰头孢噻肟的制备方法 | |
CN111233894B (zh) | 一种头孢妥仑匹酯δ3异构体的制备方法 | |
CN104650048B (zh) | 一种奥美沙坦酯缩合物的纯化方法 | |
CN112745337B (zh) | 一种头孢呋辛酸的制备方法 | |
CN107417704B (zh) | 一种头孢匹林钠的精制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Suoqing Inventor after: Hu Limin Inventor after: Jia Quan Inventor after: Tian Hongnian Inventor after: Ren Feng Inventor after: Wei Baojun Inventor after: Liu Shubin Inventor after: Zhang Hong Inventor after: Li He Inventor before: Zhang Suoqing Inventor before: Hu Limin Inventor before: Jia Quan Inventor before: Tian Hongnian Inventor before: Ren Feng Inventor before: Wei Baojun Inventor before: Liu Shubin |
|
CB03 | Change of inventor or designer information |